Loading...
Drug Pricing Controls And Approval Delays Will Curb Viability
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-66.2%7D
8.1%1Y
-66.2%7D
8.1%You can edit this narrative until Aug 22 10:33 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 22 10:33 PM. Then, changes will post as Updates.